If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...

Semaglutide, also known by the brand names Ozempic and Wegovy, is quickly becoming a popular weight-loss medication. (Getty Images) Like nearly 50% of Americans, Talia (not her real name) had ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older ...

Semaglutide has been described as a "game changer" for treating obesity and was FDA-approved for weight loss in 2021 under the brand name Wegovy. It's also available as Ozempic, which is the same ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections.

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

As obesity becomes an increasingly common health concern in India, many individuals are turning to bariatric surgery and weight loss injections to manage their weight and improve overall well-being.